Cargando…
An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancer
Activating mutations of KRAS are nearly ubiquitous in pancreatic adenocarcinomas occurring in greater than 90% of cases. Cellular transformation by oncogenic RAS requires the RHO guanine exchange factor ARHGEF2 (also known as GEF-H1) for tumor growth and survival. Here, we find oncogenic KRAS activa...
Autores principales: | Kent, Oliver A., Sandí, María-José, Burston, Helen E., Brown, Kevin R., Rottapel, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354848/ https://www.ncbi.nlm.nih.gov/pubmed/27835861 http://dx.doi.org/10.18632/oncotarget.13152 |
Ejemplares similares
-
Co-dependency between KRAS addiction and ARHGEF2 promotes an adaptive escape from MAPK pathway inhibition
por: Kent, Oliver A., et al.
Publicado: (2017) -
The potential role of Arhgef33 RhoGEF in foveal development in the zebra finch retina
por: Sugiyama, Takefumi, et al.
Publicado: (2020) -
Key transcriptional effectors of the pancreatic acinar phenotype and oncogenic transformation
por: Azevedo-Pouly, Ana, et al.
Publicado: (2023) -
ARHGEF4 Regulates an Essential Oncogenic Program in t(12;21)-Associated Acute Lymphoblastic Leukemia
por: Virely, Clemence, et al.
Publicado: (2020) -
Oncogenic KRAS signalling in pancreatic cancer
por: Eser, S, et al.
Publicado: (2014)